Long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52‐week postmarketing clinical study ( TWINKLE )

Documenti analoghi

• Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post‐hoc analysis of imeglimin clinical trial data
  di: Jumpei Ito, et al.
  Pubblicazione: (2024)
• Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data‐driven cluster analysis: A post‐hoc analysis of imeglimin clinical trial data
  di: Katsuhiko Hagi, et al.
  Pubblicazione: (2024)
• Efficacy and safety of imeglimin add‐on to DPP ‐4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: An interim analysis of the randomised, double‐blind FAMILIAR trial
  di: Kohei Kaku, et al.
  Pubblicazione: (2025)
• TWINKLE, CHASE AND SKYE
  di: CALIS, FLORENCE GALE A.
  Pubblicazione: (2025)
• A Simple but Effective Closed-form Solution for Extreme Multi-label Learning
  di: Onishi, Kazuma, et al.
  Pubblicazione: (2025)